Immunolipoplexes: an efficient, non-viral alternative for trasfection of human dendritic cells with potential for clinical vaccination

P H Tan, S C Beutelspacher, Y H Wang, M O McClure, M A Ritter, G Lombardi, A J T George

    Research output: Contribution to journalArticlepeer-review

    48 Citations (Scopus)


    Genetic manipulation of dendritic cells (DCs) is important in the context of using either mature DCs to immunize patients or immature DCs to induce tolerance. Here, we describe a novel method of transfecting monocyte-derived human DCs using immunolipoplexes containing anti-CD71 or anti-CD205 monoclonal Abs. This results in up to 20% transfection, which can be increased to 20-30% if the immunolipoplexes are used to transfect CD14(+) monocytes prior to differentiation into DCs. Transfected DCs can be substantially enriched using a drug-selection protocol during differentiation. Unlike adenoviral transduction, this nonviral transfection does not alter the expression of costimulatory molecules or the production of proinflammatory cytokines by DCs. In addition, DC function is unaltered, as assessed by mixed lymphocyte reactions. To test the feasibility of the immunolipoplexes and selection protocol for therapeutic intervention, we transfected DCs with the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO). Allogeneic T cells exposed to IDO-expressing DCs did not proliferate, secreted more IL-10 and less Th1 and Th2 cytokines, and had a higher amount of apoptosis than T cells incubated with control DCs. Furthermore the remaining T cells were rendered anergic to further stimulation by allogeneic DC. These immunolipoplexes, which can be easily and rapidly assembled, have potential for clinical immunization, in particular for tolerance induction protocols
    Original languageEnglish
    Pages (from-to)790 - 800
    Number of pages11
    JournalMolecular Therapy
    Issue number5
    Publication statusPublished - May 2005


    Dive into the research topics of 'Immunolipoplexes: an efficient, non-viral alternative for trasfection of human dendritic cells with potential for clinical vaccination'. Together they form a unique fingerprint.

    Cite this